CL
CNTB

CSS LLC’s Connect Biopharma Holdings CNTB Stock Holding History

CSS LLC’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,721
Closed -$50K – 978
2022
Q3 		$50K Buy
38,721
+18,721
+94% +$22.5K ﹤0.01% 881
2022
Q2 		$17K Hold
20,000
– – ﹤0.01% 1002
2022
Q1 		$60K Buy
+20,000
New +$84.4K ﹤0.01% 991

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CSS LLC's CNTB Position: Q4 2022 in Review

CSS LLC sold out of Connect Biopharma Holdings (CNTB) in Q4 2022, closing a stake of 38,721 shares — an estimated $50K sold.

CSS LLC first reported a position in CNTB in Q1 2022 and held it in 3 quarters. The position peaked at $60K in Q1 2022. 20 funds tracked by Wall St. Rank hold CNTB as of Q4 2022.

  • CSS LLC reported no remaining Connect Biopharma Holdings position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 38,721 Connect Biopharma Holdings shares in Q4 2022, an estimated $50K.
  • CSS LLC first reported a position in Connect Biopharma Holdings in Q1 2022 and held it in 3 quarters.
  • CSS LLC's Connect Biopharma Holdings position peaked at $60K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.